|
|
|
|
|
Welcome |
|
|
Mark your calendar now and plan to attend the Symposium on Cardiovascular Regenerative Medicine on October 1–2, 2007.
Sponsored by the National Heart, Lung, and Blood Institute (NHLBI) and the Foundation for the National Institutes of Health, this symposium will focus on adult stem cell therapies for cardiovascular disease, highlighting both basic research and clinical applications. Research experts involved in the basic science of stem cell biology, as well as clinical cardiovascular medicine experts, will discuss the emerging science, preclinical animal models, and the clinical applications to cardiovascular disease.
|
|
|
|
|
|
|
|
|
|
Symposium Goals:
- To provide a forum that will stimulate discussion about the basic principles of tissue specification in stem cell biology and cardiovascular development.
- To emphasize recent discoveries that will facilitate moving stem cell biology from bench to bedside for treatment of cardiovascular disease.
- To identify the areas of opportunity for application of regenerative therapies to cardiovascular disease.
- To discuss the impact of recent cell-based clinical trials on treatment strategies for cardiovascular disease.
|
|
|
|
|
|
|
|
|
|
Confirmed Speakers:
- Kari Alitalo, M.D., Ph.D., University of Helsinki (Finland)
- Piero Anversa, M.D., New York Medical College
- Takayuki Asahara, M.D., Ph.D., RIKEN Center for Developmental Biology/IBRI, Tokai University (Japan)
- Mickie Bhatia, Ph.D., McMaster University (Canada)
- Kenneth R. Chien, M.D., Ph.D., Harvard Medical School
- Stefanie Dimmeler, Ph.D., University of Frankfurt (Germany)
- Dieter Egli, Ph.D., Harvard Medical School
- Jonathan A. Epstein, M.D., University of Pennsylvania School of Medicine
- Loren J. Field, Ph.D., Indiana University School of Medicine
- Joshua M. Hare, M.D., Miller School of Medicine–University of Miami
- Richard Harvey, Ph.D., Victor Chang Cardiac Research Institute, University of New South Wales (Australia)
- Natalia B. Ivanova, Ph.D., Princeton University
- Bernhard Kuhn, M.D., Children's Hospital, Boston
- Albert C. Lardo, Ph.D., Johns Hopkins University School of Medicine
- Richard T. Lee, M.D., Brigham and Women's Hospital
- Ronglih Liao, Ph.D., Brigham and Women's Hospital
- Douglas W. Losordo, M.D., Northwestern University
- Eduardo Marbán, M.D., Ph.D., Johns Hopkins University School of Medicine
- Philippe Menasché, M.D., Ph.D., Hôpital Européen Georges Pompidou (France)
- Charles E. Murry, M.D., Ph.D., University of Washington Medical Center
- Stuart H. Orkin, M.D., Harvard Medical School
- Paul R. Riley, Ph.D., Institute of Child Health (United Kingdom)
- David T. Scadden, M.D., Harvard Medical School and Massachusetts General Hospital
- Michael D. Schneider, M.D., Imperial College London (United Kingdom)
- Deepak Srivastava, M.D., University of California, San Francisco
- Catherine
Verfaillie, M.D., Katholieke Universiteit Leuven (Belgium)
- Shinya Yamanaka, M.D., Ph.D., Kyoto University (Japan) and University of California, San Francisco
- Mervin C. Yoder, Jr., M.D., Indiana University School of Medicine
- Andreas M. Zeiher, M.D., University of Frankfurt (Germany)
|
|
|
|
|
|
|
|
|
|
Abstract Submissions:
Abstracts, to be presented during the
poster session on October 1, are requested and encouraged.
Guidelines for submission are on the website. This social hour will
provide an opportunity for informal discussions and the development of
new collaborative interactions.
|
|
|
|
|
|
|
|
|
|
Great
potential exists for future applications of stem cell biology to the
treatment of cardiovascular diseases. Our challenge is to bridge the
gap between knowledge and clinical applications. We hope that you will
find the information and discussion in this symposium stimulating to
your own research efforts.
We look forward to seeing you in
October.
The Symposium Organizing
Committee
- Elizabeth G. Nabel, M.D., Director, NHLBI
- Manfred Boehm, M.D., Cardiology Branch, Division of Intramural Research, NHLBI
- Kenneth R. Chien, M.D., Ph.D., Harvard Medical School
- Thomas R. Cimato, M.D., Ph.D., State University of New York at Buffalo School of Medicine and Biomedical Sciences
- Cynthia Dunbar, M.D., Hematology Branch, Division of Intramural Research, NHLBI
- Joshua M. Hare, M.D., Miller School of Medicine–University of Miami
- Cecilia Lo, Ph.D., Laboratory of Developmental Biology, Division of Intramural Research, NHLBI
- David T. Scadden, M.D., Harvard Medical School and Massachusetts General Hospital
- Michael D. Schneider, M.D., Imperial College London
- John W. Thomas, Ph.D., Division of Blood Diseases and Resources, NHLBI
Last updated: September 26, 2007
to top |
|
|
|
|
|
|
|
|